Literature DB >> 11022594

Use of a critical pathway for the management of community-acquired pneumonia: the CAPITAL Study.

D Farquhar.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11022594      PMCID： PMC80189     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.

Authors:  T J Marrie; C Y Lau; S L Wheeler; C J Wong; M K Vandervoort; B G Feagan
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

2.  Evidence-based disease management.

Authors:  G Ellrodt; D J Cook; J Lee; M Cho; D Hunt; S Weingarten
Journal:  JAMA       Date:  1997-11-26       Impact factor: 56.272

3.  Critical pathways as a strategy for improving care: problems and potential.

Authors:  S D Pearson; D Goulart-Fisher; T H Lee
Journal:  Ann Intern Med       Date:  1995-12-15       Impact factor: 25.391
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.